Chicago Illinois based Dystrogen Therapeutics is raising $5,000,000.00 in a new round of Venture Capital investment.
Chicago, IL – According to filings with the U.S. Securities and Exchange Commission, Dystrogen Therapeutics is raising $5,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Kris…